Tumor Testing, ctDNA Finds More Patients Eligible for Personalized Drugs
Concurrent circulating tumor DNA and tissue-based testing identified more patients eligible for personalized cancer care than either of the tests done alone.
Stay updated with breaking news from Tumor Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Concurrent circulating tumor DNA and tissue-based testing identified more patients eligible for personalized cancer care than either of the tests done alone.
Lollapalooza India 2024, set to take place on January 27 and 28 in Mumbai, will be headlined by Jonas Brothers, Halsey, and Sting.
Rates of next-generation sequencing (NGS) more than doubled once a nurse navigation program was implemented.
Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.
In this third episode of OncChats: Understanding Lynch Syndrome and Cancer Risk, Fay Kastrinos, MD, MPH, discusses testing guidance for identifying Lynch syndrome.